Position in BCRX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$22,557,310
+$2,520,331 QoQ
Shares Held
2,255,731
+7.2% QoQ
Ownership
0.883%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 316 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $2,153,058,366 across 55 Drug Manufacturers - Specialty & Generic names. BCRX ranks #17 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
5,542,234 | $398,264,931 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
7,956,873 | $269,578,854 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
430,844 | $233,444,201 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
1,259,717 | $212,312,700 | |
| 5 | VTRS |
Viatris Inc
|
10,038,691 | $159,414,410 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
4,256,056 | $104,741,534 | |
| 7 | ALKS |
Alkermes plc.
|
1,831,619 | $95,976,834 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
818,394 | $90,792,627 |
All Filings in BCRX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,557,310 | 2,255,731 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $20,036,979 | 2,104,725 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $14,483,841 | 1,856,903 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $14,360,602 | 1,892,043 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $17,147,010 | 1,913,729 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $14,664,433 | 1,955,258 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $15,076,928 | 2,004,911 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $14,143,029 | 1,860,925 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $10,844,434 | 1,754,763 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $9,170,287 | 1,805,175 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $11,062,127 | 1,846,766 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $13,116,852 | 1,852,663 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $12,936,146 | 1,837,521 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $14,704,243 | 1,763,099 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $20,060,839 | 1,747,460 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $22,639,565 | 1,796,791 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $19,222,631 | 1,816,884 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $29,266,340 | 1,799,898 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $25,774,958 | 1,861,008 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $35,028,080 | 2,437,584 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $38,897,531 | 2,460,312 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $19,853,139 | 1,952,128 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $15,370,144 | 2,063,107 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $7,191,064 | 2,090,426 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $9,178,354 | 1,928,226 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $3,738,260 | 1,869,130 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||